Bionano Genomics appoints Dr. Alex Hastie as Chief Scientific Officer
Bionano Genomics announced the hiring of Alex Hastie, Ph.D., as Chief Scientific Officer, effective July 20, 2026. His return signals a strategic focus on advancing optical genome mapping and research applications in oncology.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day